Cargando…
Biventricular Levitronix CentriMag Assist Device: A “Bridge to Recovery” Solution in Patients with Acute Fulminant Myocarditis
Fulminant myocarditis (FM) represents a crucial cardiac pathology with extensive hemodynamic compromise occurring in a previously healthy patient. Early death occurs because of acute cardiac decompensation from inflammation, necrosis, and myocytolysis. Nevertheless, in this situation implantation of...
Autores principales: | Vollroth, Marcel, Barten, Markus J., Mohr, Friedrich W., Garbade, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514809/ https://www.ncbi.nlm.nih.gov/pubmed/23227413 http://dx.doi.org/10.1155/2012/907490 |
Ejemplares similares
-
Use of CentriMag for refractory cardiogenic shock in a puerperal woman: case report
por: Pêgo-Fernandes, Paulo Manuel, et al.
Publicado: (2021) -
Hemocompatibility of new magnetically-levitated centrifugal pump technology compared to the CentriMag adult pump
por: Schibilsky, David, et al.
Publicado: (2020) -
How to Optimize ECLS Results beyond Ventricular Unloading: From ECMO to CentriMag(®) eVAD
por: Tarzia, Vincenzo, et al.
Publicado: (2022) -
The CentriMag Centrifugal Blood Pump as a Benchmark for In Vitro Testing of Hemocompatibility in Implantable Ventricular Assist Devices
por: Chan, Chris HH, et al.
Publicado: (2015) -
Outcome of CentriMag™ extracorporeal mechanical circulatory support use in critical cardiogenic shock (INTERMACS 1) patients
por: Mehta, Vipin, et al.
Publicado: (2020)